Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
S-1 is an oral fluoropyrimidine with demonstrated efficacy on gastric cancer and colorectal
cancer. The new regimen with Oxaliplatin and leucovorin is expected to achieve more
encouraging efficacy on colorectal cancer. This study is to explore the feasibility of the
SOL regimen on efficacy and tolerability on Chinese colorectal cancer patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Shen Lin
Collaborators:
307 Hospital of PLA Beijing Union Hosptial Hebei Provincial Cancer Hospital Tianjin Medical University Cancer Institute and Hospital